These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30360810)

  • 21. Tailoring chemical compositions of biodegradable mesoporous organosilica nanoparticles for controlled slow release of chemotherapeutic drug.
    Mai NXD; Nguyen TT; Vong LB; Dang MD; Nguyen TTT; Nguyen LHT; Ta HKT; Nguyen TH; Phan TB; Doan TLH
    Mater Sci Eng C Mater Biol Appl; 2021 Aug; 127():112232. PubMed ID: 34225873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
    Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
    Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anisotropic growth-induced synthesis of dual-compartment Janus mesoporous silica nanoparticles for bimodal triggered drugs delivery.
    Li X; Zhou L; Wei Y; El-Toni AM; Zhang F; Zhao D
    J Am Chem Soc; 2014 Oct; 136(42):15086-92. PubMed ID: 25251874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of Boronophenylalanine-Loaded Biodegradable Periodic Mesoporous Organosilica Nanoparticles for BNCT Cancer Therapy.
    Tamanoi F; Chinnathambi S; Laird M; Komatsu A; Birault A; Takata T; Doan TL; Mai NXD; Raitano A; Morrison K; Suzuki M; Matsumoto K
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Facile Multi-interface Transformation Approach to Monodisperse Multiple-Shelled Periodic Mesoporous Organosilica Hollow Spheres.
    Teng Z; Su X; Zheng Y; Zhang J; Liu Y; Wang S; Wu J; Chen G; Wang J; Zhao D; Lu G
    J Am Chem Soc; 2015 Jun; 137(24):7935-44. PubMed ID: 26030506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite.
    Hao X; Hu X; Zhang C; Chen S; Li Z; Yang X; Liu H; Jia G; Liu D; Ge K; Liang XJ; Zhang J
    ACS Nano; 2015 Oct; 9(10):9614-25. PubMed ID: 26316321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodegradable ethylene-bis(propyl)disulfide-based periodic mesoporous organosilica nanorods and nanospheres for efficient in-vitro drug delivery.
    Croissant J; Cattoën X; Man MW; Gallud A; Raehm L; Trens P; Maynadier M; Durand JO
    Adv Mater; 2014 Sep; 26(35):6174-80. PubMed ID: 25042639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance.
    Jia L; Li Z; Shen J; Zheng D; Tian X; Guo H; Chang P
    Int J Pharm; 2015 Jul; 489(1-2):318-30. PubMed ID: 25956050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hierarchical mesoporous silica nanoparticles for tailorable drug release.
    Wu W; Ye C; Xiao H; Sun X; Qu W; Li X; Chen M; Li J
    Int J Pharm; 2016 Sep; 511(1):65-72. PubMed ID: 27374197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy.
    Mekaru H; Lu J; Tamanoi F
    Adv Drug Deliv Rev; 2015 Dec; 95():40-9. PubMed ID: 26434537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
    Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K
    Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells.
    Xu W; Ge P; Niu B; Zhang X; Liu J; Xie J
    J Colloid Interface Sci; 2018 Oct; 527():141-150. PubMed ID: 29787950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesoporous silica nanoparticles in nanotechnology.
    Douroumis D; Onyesom I; Maniruzzaman M; Mitchell J
    Crit Rev Biotechnol; 2013 Sep; 33(3):229-45. PubMed ID: 22724458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aptamer-based nanoparticles for cancer targeting.
    Sá LT; Simmons S; Missailidis S; da Silva MI; Santos-Oliveira R
    J Drug Target; 2013 May; 21(5):427-34. PubMed ID: 23350808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of iron oxide mesoporous magnetic microparticles as novel multidrug carriers for synergistic anticancer therapy and deep tumor penetration.
    El-Boubbou K; Ali R; Al-Zahrani H; Trivilegio T; Alanazi AH; Khan AL; Boudjelal M; AlKushi A
    Sci Rep; 2019 Jul; 9(1):9481. PubMed ID: 31263250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment.
    Ahmadi Nasab N; Hassani Kumleh H; Beygzadeh M; Teimourian S; Kazemzad M
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):75-81. PubMed ID: 28278578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
    Li X; Wu M; Pan L; Shi J
    Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.